PMID- 21424898 OWN - NLM STAT- MEDLINE DCOM- 20111004 LR - 20211020 IS - 1432-0428 (Electronic) IS - 0012-186X (Linking) VI - 54 IP - 7 DP - 2011 Jul TI - Synaptotagmin-7 as a positive regulator of glucose-induced glucagon-like peptide-1 secretion in mice. PG - 1824-30 LID - 10.1007/s00125-011-2119-3 [doi] AB - AIMS/HYPOTHESIS: Glucagon-like peptide-1 (GLP-1), a hormone with potent antihyperglycaemic effects, is produced and secreted from highly specialised gut endocrine L-cells. It regulates glucose homeostasis by promoting glucose-dependent insulin secretion, suppressing glucagon secretion and enhancing insulin sensitivity. Similar to islet alpha and beta cells, L-cells are electrically excitable, and express calcium channels and ATP-sensitive potassium channels. GLP-1 is also stored in secretory granules, the exocytosis of which is triggered by increased intracellular calcium levels. Although the calcium dependence of GLP-1 granule exocytosis is well established, the identities of calcium-sensing proteins in GLP-1 secretion remain elusive. Here we tested whether synaptotagmin-7, a calcium sensor in pancreatic alpha and beta cells, regulates GLP-1 secretion. METHODS: We studied GLP-1 secretion using synaptotagmin-7 knockout (KO) mice and GLUTag cells with lentiviral-mediated synaptotagmin-7 silencing. RESULTS: We found that synaptotagmin-7 was co-localised with GLP-1 in intestinal L-cells. GLP-1 secretion was impaired in synaptotagmin-7 KO mice when they were challenged by glucose ingestion. Lentiviral knockdown (KD) of synaptotagmin-7 in GLUTag cells led to similar reductions in GLP-1 secretion, as determined by biochemical assays and by membrane capacitance measurements. Calcium response was not altered in synaptotagmin-7 KD cells. CONCLUSIONS/INTERPRETATION: These results demonstrate that synaptotagmin-7 functions as a positive regulator of GLP-1 secretion in intestinal L-cells and GLUTag cells, consistent with its proposed role as a calcium sensor in GLP-1 secretion. FAU - Gustavsson, N AU - Gustavsson N AD - Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A STAR), 02-02 Helios, 11 Biopolis Way, Singapore, 138667, Republic of Singapore. FAU - Wang, Y AU - Wang Y FAU - Kang, Y AU - Kang Y FAU - Seah, T AU - Seah T FAU - Chua, S AU - Chua S FAU - Radda, G K AU - Radda GK FAU - Han, W AU - Han W LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110322 PL - Germany TA - Diabetologia JT - Diabetologia JID - 0006777 RN - 0 (RNA, Small Interfering) RN - 134193-27-4 (Synaptotagmins) RN - 89750-14-1 (Glucagon-Like Peptide 1) SB - IM MH - Animals MH - Blotting, Western MH - Cells, Cultured MH - Electrophysiology MH - Glucagon-Like Peptide 1/*metabolism MH - Immunohistochemistry MH - Intestines/*cytology MH - Mice MH - Mice, Knockout MH - Polymerase Chain Reaction MH - RNA, Small Interfering/genetics MH - Synaptotagmins/genetics/*metabolism EDAT- 2011/03/23 06:00 MHDA- 2011/10/05 06:00 CRDT- 2011/03/23 06:00 PHST- 2011/01/03 00:00 [received] PHST- 2011/02/22 00:00 [accepted] PHST- 2011/03/23 06:00 [entrez] PHST- 2011/03/23 06:00 [pubmed] PHST- 2011/10/05 06:00 [medline] AID - 10.1007/s00125-011-2119-3 [doi] PST - ppublish SO - Diabetologia. 2011 Jul;54(7):1824-30. doi: 10.1007/s00125-011-2119-3. Epub 2011 Mar 22.